Humanwell Healthcare (Group) Co.,Ltd. (SHA:600079)
China · Delayed Price · Currency is CNY 19.28
+0.05 (0.26%)
At close: Feb 6, 2026
SHA:600079 Market Cap
SHA:600079 has a market cap or net worth of 31.47 billion as of February 6, 2026. Its market cap has decreased by -5.72% in one year.
Market Cap
31.47B
Enterprise Value
38.67B
Revenue
24.18B
Ranking
n/a
PE Ratio
22.06
Stock Price
19.28
Market Cap Chart
Since January 2, 2001, SHA:600079's market cap has increased from 2.30B to 31.47B, an increase of 1,270.72%. That is a compound annual growth rate of 10.99%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 6, 2026 | 31.47B | 6.46% |
| Dec 31, 2025 | 29.56B | -21.41% |
| Dec 31, 2024 | 37.61B | -5.96% |
| Dec 29, 2023 | 40.00B | 4.04% |
| Dec 30, 2022 | 38.44B | 6.06% |
| Dec 31, 2021 | 36.25B | -30.05% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Changchun High-Tech Industry (Group) | 36.73B |
| Dong-E-E-Jiao | 35.53B |
| Tianjin Pharmaceutical Da Ren Tang Group Corporation | 30.62B |
| Shijiazhuang Yiling Pharmaceutical | 29.45B |
| Livzon Pharmaceutical Group | 28.95B |
| Chengdu Kanghong Pharmaceutical Group | 26.72B |
| Kangmei Pharmaceutical | 26.27B |
| Dizal (Jiangsu) Pharmaceutical | 25.01B |